Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2009;119:139-146
doi: 10.1161/CIRCULATIONAHA.108.805887
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goldstein, D. S.
Right arrow Articles by Sharabi, Y.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Goldstein, D. S.
Right arrow Articles by Sharabi, Y.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Other hypertension
Right arrow Clinical Studies
Right arrow Nuclear cardiology and PET

(Circulation. 2009;119:139-146.)
© 2009 American Heart Association, Inc.


Contemporary Reviews in Cardiovascular Medicine

Neurogenic Orthostatic Hypotension

A Pathophysiological Approach

David S. Goldstein, MD, PhD; Yehonatan Sharabi, MD

From the Clinical Neurocardiology Section, Clinical Neurosciences Program, Division of Intramural Research, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md (D.S.G., Y.S.); and Hypertension Unit, Sheba Medical Center, Tel-HaShomer, and Sackler Faculty of Medicine, Tel Aviv, Israel (Y.S.).

Correspondence to Dr David S. Goldstein, Bldg 10, Room 6N252, 10 Center Dr, MSC-1620, Bethesda, Md 20892-1620. E-mail goldsteind@ninds.nih.gov


Key Words: hypotension • nervous system, sympathetic • norepinephrine • orthostatic hypotension • tomography


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Orthostatic hypotension (OH) is defined as a persistent, consistent, orthostatic fall in systolic blood pressure of ≥20 mm Hg or diastolic pressure of ≥10 mm Hg by 3 minutes of standing up.1 Acute, unexpected, episodic falls in blood pressure while standing, as in neurocardiogenic syncope, do not satisfy criteria for OH.

Medical records for {approx}0.4% of all hospitalizations in the United States include OH as a diagnosis, and of these {approx}17% have OH as the primary diagnosis.2 OH is associated with increased mortality in middle-aged adults3 and occurs especially commonly in the elderly, with a prevalence in the United States of {approx}12%.4 The rate of hospitalization for nonacute OH increases exponentially with age.2 Therefore, as the US population ages, the prevalence of OH and the incidence of OH-related morbidity are likely to increase.

OH can be an asymptomatic sign or manifest as symptoms that range from lightheadedness to loss of consciousness. In our experience, patients with OH do not typically present with recurrent syncope because they come to recognize and respond to premonitory symptoms such as generalized weakness, dizziness, fading vision, or lightheadedness that are relieved by lying down. Instead, OH patients often present with orthostatic intolerance and recurrent falls, an important risk factor for hip fracture and head trauma.

Moreover, OH often occurs concurrently with supine hypertension, which can be severe.5 The combination of OH and supine hypertension poses a challenging clinical dilemma because the clinician must balance the risk of chronic high blood pressure versus the immediate risk . . . [Full Text of this Article]